8-KMaterial AgreementsShareholder MattersCorporate Changes+1

BIOGEN INC. 8-K Report, Material Agreement (Jun 7, 2011)

Filed June 7, 2011For Securities:BIIB

Summary

Biogen Idec Inc. (now Biogen Inc.) filed this Form 8-K on June 7, 2011, to report on significant corporate governance changes and material agreements approved by its Board of Directors and stockholders. Key among these was the declassification of the Board of Directors, meaning all directors will now stand for election annually, a move approved by stockholders at the 2011 Annual Meeting. This change aims to enhance director accountability to shareholders. The filing also details the adoption of a new form of indemnification agreement for directors and executive officers, which will supersede prior agreements. This new agreement provides for indemnification against certain expenses, judgments, and losses incurred in their official capacities, and allows for the advancement of defense expenses. Additionally, a new bylaw provision designates the Delaware Court of Chancery as the exclusive forum for resolving certain corporate disputes, intended to streamline legal processes and reduce litigation costs.

Key Highlights

  • 1Biogen Idec Inc. stockholders approved an amendment to the company's Certificate of Incorporation to declassify the Board of Directors, initiating annual director elections.
  • 2A new form of indemnification agreement was approved for directors and executive officers, providing them with enhanced protection and expense advancement for legal proceedings related to their roles.
  • 3The company's Bylaws were amended to establish the Delaware Court of Chancery as the exclusive forum for resolving derivative actions and other specific corporate law claims.
  • 4All twelve director nominees presented at the 2011 Annual Meeting were elected to serve a one-year term, reflecting the newly declassified board structure.
  • 5PricewaterhouseCoopers LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2011.
  • 6A non-binding advisory vote on executive compensation (Say-on-Pay) was approved, with stockholders favoring an annual frequency for this vote.

Frequently Asked Questions

Declassifying the Board of Directors means that all directors will now be elected annually by shareholders. Previously, the board was 'classified,' meaning only a portion of the directors were up for election each year. This change enhances director accountability to shareholders, as each director faces re-election annually.

The new indemnification agreement provides that Biogen Idec Inc. will indemnify its directors and executive officers against expenses, judgments, and other losses arising from their service to the company. It also allows the company to advance expenses for legal defense. This offers increased protection and support for individuals serving in these key leadership roles.

By designating the Delaware Court of Chancery as the exclusive forum for derivative actions and claims related to Delaware law, the company aims to consolidate litigation in a specialized court with deep expertise in corporate law. This is intended to lead to more efficient and consistent resolution of such disputes, potentially reducing legal costs and uncertainty.

Shareholders approved the compensation paid to Biogen's named executive officers in a non-binding advisory vote. Furthermore, shareholders voted in favor of holding this advisory vote on executive compensation annually, indicating a preference for more frequent shareholder input on executive pay.